amodiaquine has been researched along with Pneumonia, Viral in 4 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, S | 1 |
| Ko, M | 1 |
| Lee, J | 1 |
| Choi, I | 1 |
| Byun, SY | 1 |
| Park, S | 1 |
| Shum, D | 1 |
| Kim, S | 1 |
| Olsen, M | 1 |
| Cook, SE | 1 |
| Huang, V | 1 |
| Pedersen, N | 1 |
| Murphy, BG | 1 |
| Ianevski, A | 1 |
| Yao, R | 1 |
| Fenstad, MH | 1 |
| Biza, S | 1 |
| Zusinaite, E | 1 |
| Reisberg, T | 1 |
| Lysvand, H | 1 |
| Løseth, K | 1 |
| Landsem, VM | 1 |
| Malmring, JF | 1 |
| Oksenych, V | 1 |
| Erlandsen, SE | 1 |
| Aas, PA | 1 |
| Hagen, L | 1 |
| Pettersen, CH | 1 |
| Tenson, T | 1 |
| Afset, JE | 1 |
| Nordbø, SA | 1 |
| Bjørås, M | 1 |
| Kainov, DE | 1 |
| Gendrot, M | 1 |
| Duflot, I | 1 |
| Boxberger, M | 1 |
| Delandre, O | 1 |
| Jardot, P | 1 |
| Le Bideau, M | 1 |
| Andreani, J | 1 |
| Fonta, I | 1 |
| Mosnier, J | 1 |
| Rolland, C | 1 |
| Hutter, S | 1 |
| La Scola, B | 1 |
| Pradines, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Silver Nanoparticles as an Oropharyngeal Product (Mouthwash) and Nasal Hygiene, by Health Personnel Working at the Tijuana General Hospital Exposed to Patients Diagnosed With Atypical Pneumonia Caused by SARS-CoV-2[NCT04894409] | 231 participants (Actual) | Interventional | 2020-04-24 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for amodiaquine and Pneumonia, Viral
| Article | Year |
|---|---|
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiop | 2020 |
Perspectives: potential therapeutic options for SARS-CoV-2 patients based on feline infectious peritonitis strategies: central nervous system invasion and drug coverage.
Topics: Adenosine Triphosphate; Amodiaquine; Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; Bet | 2020 |
Potential Antiviral Options against SARS-CoV-2 Infection.
Topics: Amodiaquine; Animals; Antiviral Agents; Betacoronavirus; Caco-2 Cells; Cell Line, Tumor; Chlorocebus | 2020 |
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Betaco | 2020 |